Mersana Therapeutics, Inc. - COM (MRSN)

Historical Portfolio Holders from Q2 2017 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
116M
Holdings value Q3 2024
$219M
Value change Q3 2024
+$3.27M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
115
Number of buys Q3 2024
47
Number of sells Q3 2024
-49
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 116M $219M +$3.27M $1.89 115
2024 Q2 114M $230M -$24M $2.01 121
2024 Q1 117M $526M +$24M $4.48 124
2023 Q4 113M $262M +$21M $2.32 104
2023 Q3 114M $144M -$76.6M $1.27 128
2023 Q2 112M $370M +$12.9M $3.29 152
2023 Q1 107M $437M +$17.6M $4.11 155
2022 Q4 101M $593M +$41.1M $5.86 150
2022 Q3 92.2M $623M +$37.7M $6.76 146
2022 Q2 88.3M $408M +$36.8M $4.62 121
2022 Q1 80.9M $323M +$33.1M $3.99 127
2021 Q4 70.2M $437M -$9.66M $6.22 120
2021 Q3 68.7M $648M -$40.8M $9.43 109
2021 Q2 69.8M $947M -$9.19M $13.58 129
2021 Q1 68.2M $1.1B -$36.2M $16.18 132
2020 Q4 68.1M $1.81B +$51.9M $26.61 151
2020 Q3 67.9M $1.26B +$48.6M $18.62 133
2020 Q2 64.7M $1.51B +$685M $23.40 132
2020 Q1 40.1M $234M +$26.1M $5.83 82
2019 Q4 35.5M $203M -$6M $5.73 69
2019 Q3 38.5M $60.8M -$6.78M $1.58 73
2019 Q2 40M $162M +$12M $4.05 77
2019 Q1 36.9M $194M +$105M $5.26 65
2018 Q4 17.2M $70M -$10.2M $4.08 48
2018 Q3 19.8M $198M +$76.4K $10.00 46
2018 Q2 19.1M $342M +$7.61M $17.86 52
2018 Q1 18.7M $295M +$23.7M $15.77 56
2017 Q4 15.5M $254M -$4.02M $16.43 45
2017 Q3 15.7M $271M +$10.6M $17.29 40
2017 Q2 17M $236M +$236M $13.97 29